ARCA biopharma (ABIO) Awarded U.S. Patent for Methods of Treatment with Bucindolol

Go back to ARCA biopharma (ABIO) Awarded U.S. Patent for Methods of Treatment with Bucindolol
ARCA BIOPHARMA (NASDAQ: ABIO) Delayed: 2.40 --0 (-0%)
Previous Close $2.40    52 Week High $6.97 
Open $2.40    52 Week Low $2.15 
Day High $2.40    P/E N/A 
Day Low $2.40    EPS $-1.48 
Volume 309,633